STAT

SEPTEMBER 19, 2024

Amid ongoing concern over the quality of medicines made in India, a major supplier of generic medicines was seen removing three truckloads of “scrap materials” from a facility that was being inspected last month by the Food and Drug Administration.

Documentation 284

Documentation Generic Medicine 284

STAT

SEPTEMBER 14, 2023

In explaining its new policy statement , the FTC noted that some drug companies have failed to follow requirements for listing patents in the so-called Orange Book in hopes of thwarting competition from lower-cost generic medicines.

Generic Medicine 316

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 316

STAT

NOVEMBER 3, 2022

A leaked draft version of a trade agreement being negotiated between the United Kingdom and India has sparked concern among civil society and patient advocacy groups that the proposed deal would impede the supply of affordable generic medicines in poor countries around the world.

Generic Medicine 252

Generic Medicine Drug Development 252

STAT

SEPTEMBER 29, 2023

A handful of the largest purveyors of generic medicines have made only halting progress to ensure their drugs are accessible for patients in low- and middle-income countries, a new analysis found.

Generic Medicine 280

Generic Medicine 280

STAT

FEBRUARY 10, 2023

WASHINGTON — Generic drugmakers lobbied hard against Democrats’ new law empowering Medicare to negotiate prescription drug prices. Giving the government such power seemed like an admission that generic medicines don’t do enough to keep costs down.

Drug Pricing 246

Drug Pricing Generic Medicine Packaging 246

STAT

MARCH 21, 2023

A leaked version of the agreement already sparked concerns last year that the proposed deal would impede the supply of affordable generic medicines in poor countries around the world. More than 200 civil society and patient advocacy groups are urging the U.K. Now, the groups are upset that the involvement of Harjinder Kang, the U.K.

Generic Medicine 251

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 251

STAT

MARCH 1, 2024

A growing number of alternative pharmacies — such as those run by Costco, Amazon, and Mark Cuban Cost Plus Drugs — may be increasingly popular with American consumers, but a new analysis finds many of the most expensive generic medicines are unavailable, prices vary widely, and savings can be modest.

Generic Medicine 305

Generic Medicine 305

STAT

MAY 23, 2023

But it’s a generic medicine — which means PBMs’ negotiating techniques don’t apply. Generic drugs compete on price. There’s just one problem: PBMs don’t have anything to do with that discrepancy. The chemo drug in question, Imatinib, costs $17,000 at CVS and just $72 at Cost Plus Drugs.

Generic Medicine 246

Generic Medicine Drug Pricing 246

STAT

NOVEMBER 7, 2023

The move comes two months after the FTC issued a policy statement noting some drug companies have failed to follow requirements for listing patents in the Food and Drug Administration’s Orange Book in hopes of thwarting competition from lower-cost generic medicines. Continue to STAT+ to read the full story…

Generic Medicine 300

Generic Medicine 300

STAT

JULY 21, 2023

The review comes in response to an inspection of Synapse facilities by Spanish regulators, who raised “serious concerns about the validity and reliability” of clinical trial data generated by the company.

Generic Medicine 246

Generic Medicine 246

Express Pharma

MARCH 2, 2025

At the initiative of Prime Minister Narendra Modi, March 7 is celebrated every year as Jan Aushadhi Diwas to enhance awareness about the scheme and promote generic medicines. Under this scheme, dedicated outlets known as Jan Aushadhi Kendras (JAKs) are opened to provide generic medicines.

Generic Medicine 76

Generic Medicine Diabetes 76

PharmaState Academy

SEPTEMBER 28, 2023

The conversation led by Gauri Chaudhari ended with Gauri Chaudhari saying it should be ‘BRANDED & GENERIC MEDICINES’. The major issues involved in the NMC decision is the price of branded medicines. In the first place are our branded generic medicines really expensive? I fully agree with her.

Generic Medicine 52

Generic Medicine 52

Express Pharma

OCTOBER 27, 2024

It’s not just a goal; it is the foundation of our global leadership, and the trust placed in us.

Generic Medicine 104

Generic Medicine Process Improvement 104

pharmaphorum

FEBRUARY 15, 2024

The FTC is investigating wholesalers and other middlemen in the pharma supply chain to assess their possible role in worsening shortages of generic medicines

Generic Medicine 113

Generic Medicine 113

Express Pharma

NOVEMBER 1, 2024

The world is increasingly looking towards India, not just for our contributions to generic medicines, but for our growing leadership in advanced areas like biologics, medical devices, and digital health.” It’s not just a goal; it is the foundation of our global leadership, and the trust placed in us.

Generic Medicine 106

Generic Medicine Process Improvement Compounding 106

Express Pharma

JANUARY 25, 2025

The Indian pharmaceutical sector is loaded with talent and has made great strides in generic medicine development. However, massive R&D expenditure is necessary to drive the next generation of discoveries. A strong pharmaceutical ecosystem relies heavily on research and development (R&D).

Generic Medicine 76

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 76

The Guardian - Pharmaceutical Industry

JANUARY 22, 2024

Roared on by the pharmaceutical industry, ministers have been using trade talks with India to push for agreement on new, extremely restrictive patent rules that would severely undermine its generic medicines industry.

Generic Medicine 90

Generic Medicine 90

Drug Channels

SEPTEMBER 10, 2020

George examines the economic impact of generic pharmaceuticals on the U.S. He argues that the generics industry provides safe, effective, and affordable medicines for many Americans. Today’s guest post comes from George Keefe, Senior Vice President of External Affairs and Public Policy at Teva Pharmaceuticals.

Generic Medicine 52

Generic Medicine 52

pharmaphorum

JUNE 19, 2024

Amazon Pharmacy is expanding its subscription service for generic medicines, making it available to Medicare patients

Generic Medicine 69

Generic Medicine 69

Express Pharma

JANUARY 7, 2025

Goldman Sachs Asset Management, to acquire a majority stake in Synthon International Holdings BV, a company engaged in developing, manufacturing, and out-licensing complex generic medicines, for a consideration of approximately $2.1 billion; AlpInvest Partners B.V. and Sixth Street Specialty Lending, investing $945.6 million.

Generic Medicine 106

Generic Medicine 106

Express Pharma

APRIL 4, 2024

Zena Health plans to strengthen its reach and democratise healthcare in Eastern India Zeno Health, omni channel platform for quality and affordable generic medicines has announced its acquisition of Kolkata-based startup Tablt Pharmacy.

Generic Medicine 104

Generic Medicine Online Pharmacies 104

European Pharmaceutical Review

MAY 27, 2025

Generic medicine Emtricitabine/Tenofovir alafenamide Viatris (emtricitabine / tenofovir alafenamide), received a positive opinion to treat adults and adolescents with human immunodeficiency virus type 1 (HIV-1). Additionally, the treatment was recommended for adults and skeletally mature adolescents with giant cell tumour of bone.

Biosimilars 59

Biosimilars Generic Medicine 59

Pharma Pathway

JANUARY 29, 2023

-Walk-In Interview for Quality Control On 1st Feb’ 2023 Job Description Felix Generics Pvt. is a pharmaceutical generics business Company. HPRA Approved (April 2021) facility for veterinary generic medicines. Parent entity based in Ireland. Manufacturing facility based at SEZ Pithampur , Indore.

Generic Medicine 84

Generic Medicine 84

Express Pharma

MAY 3, 2023

We are committed to maintaining strict adherence to the highest quality standards and to ensuring delivery of safe and effective generic medicines to our patients in the US and around the world.” ” The post Indoco receives EIR for its manufacturing facility in Goa (Plant I) appeared first on Express Pharma.

Dosage 97

Dosage Generic Medicine 97

Express Pharma

APRIL 7, 2025

This strategy has been particularly prominent in countries like India, which is one of the largest producers of generic medicines and has been a key player in the global FDC market.

Generic Medicine 66

Generic Medicine Diabetes Pharmaceutical Companies Pharmaceutical Companies 66

Express Pharma

MARCH 12, 2025

The FDA has an established office in India overseeing the number of qualified manufacturers supplying generic medicines to the US. The United States Food and Drug Administration (FDA) conducts rigorous inspections of both domestic and foreign manufacturing facilities, including those in India.

Generic Medicine 66

Generic Medicine Process Improvement Dosage Pharmaceutical Manufacturing 66

The Guardian - Pharmaceutical Industry

AUGUST 15, 2023

Indian Medical Association says that testing is substandard in the manufacture of generic medicines with ‘no guarantee of quality’ Indian doctors have been told they can no longer prescribe branded drugs for their patients, provoking vehement protest from the Indian Medical Association [IMA].

Generic Medicine 67

Generic Medicine 67

Pharmaceutical Technology

DECEMBER 15, 2022

Europe also enforces rigid pricing policies for essential medicines to be available at the lowest possible price. These factors combined affect the commercial viability of generic medicines, with some European drugmakers already warning that they may stop making cheap generic medicines.

Generic Medicine 98

Generic Medicine Drug Pricing Biosimilars Hospitals 98

Express Pharma

AUGUST 29, 2023

The Drug Master File (DMF) has all the information on an API (Active Pharmaceutical Ingredient/Raw material for medicine) Mankind Pharma has introduced 120 DMF (Drug Master File) Quality Medicines in the Indian market. This initiative aims to ensure universal access to medicines of international calibre.

Generic Medicine 98

Generic Medicine Packaging 98

European Pharmaceutical Review

JANUARY 30, 2024

Ryzneuta (efbemalenograstim alfa) received a positive opinion from the CHMP as a medicine to reduce the duration of neutropenia and the incidence of febrile neutropenia due to chemotherapy. Additionally, a positive opinion for Niapelf (paliperidone), a generic medicine for schizophrenia was adopted in the meeting.

Generic Medicine 98

Generic Medicine Chemotherapy Hospitals 98

European Pharmaceutical Review

MARCH 14, 2023

The CJEU stressed that identical medicinal products are not those that are only therapeutically equivalent (as generics are to reference products), but they should be identical in all respects.

Packaging 98

Packaging Generic Medicine Labelling Pharmaceutical Companies 98

pharmaphorum

MARCH 14, 2022

For Sandoz, the acquisition gives it a technology platform in an area of the generic medicines market with a relatively high barrier to entry, as developing inhaled medicines poses “comparatively high technical complexity,” according to Sandoz chief executive Richard Saynor.

Generic Medicine 104

Generic Medicine Biosimilars 104

pharmaphorum

OCTOBER 6, 2022

” It also sees continued growth in cardiovascular and venous diseases, as well as in generic medicines, and says its new visual identity (see above) reflects its “uniqueness” as an “independent group, governed by a foundation, committed to therapeutic progress to serve patient needs.”

Generic Medicine 98

Generic Medicine Chemotherapy 98

Express Pharma

AUGUST 4, 2024

.” Dr Chandrashekar Ranga, Joint Drugs Controller, India, will discuss the obstacles regulators face in the digital era; Dr Stewart Geary, Global Safety Officer, Eisai and a Fellow of DIA, will provide updates on behalf of the Council for International Organizations of Medical Sciences (CIOMS) Working Group XII on Benefit-Risk Balance for Medicinal (..)

Generic Medicine 106

Generic Medicine Labelling 106

pharmaphorum

JANUARY 13, 2022

Over the same period, total gross expenditures on brand and generic medicines nearly doubled – from $268 billion to $517 billion, according to the report.

Payment Processing 111

Payment Processing Generic Medicine Hospitals 111

European Pharmaceutical Review

AUGUST 25, 2022

Meanwhile, Sandoz would leverage its strong brand and sustain its leading global position by continuing to invest in the key strategic areas of Biosimilars, Antibiotics and Generic Medicines. Working to deliver on its vision of access to patients. Additional transaction details.

Biosimilars 98

Biosimilars Generic Medicine 98

pharmaphorum

JANUARY 30, 2023

With the production of generic medicine being concentrated in China and India, the ability to flexibly influence the supply of generic medicine, which most antibiotics are, is relatively limited. Larger questions remain around the way in which to support manufacturers to invest in production capabilities for antibiotics.

Generic Medicine 104

Generic Medicine Packaging Labelling 104